Table 1.
Patient characteristics
| Gender (male/female) | 585/371 |
| Age, median (range) | 69.7 (22—92) |
| Comorbidity | 550 (57.5%) |
| Interstitial lung disease (%) | 22 (2.3%) |
| Malignancy (%) | 161 (16.8%) |
| Diabetes mellitus (%) | 136 (14.2%) |
| Asthma (%) | 28 (2.9%) |
| Arrhythmia (%) | 26 (2.7%) |
| Angina pectoris (%) | 70 (7.3%) |
| Charlson comorbidity index (0/1/2/3/4/5/6/7) | 539/201/152/47/13/3/1/1 |
| Smoking index, median (range) | 540 (0–3600) |
| %VC, median (range) | 100.1 (51.5–177.7) |
| FEV1%, median (range) | 73.7 (30.5–99.4) |
| Lobe of lung cancer | |
| RU/RM/RL/LU/LL | 289/58/231/220/158 |
| Operative approach | |
| RATS/C-VATS/H-VATS/Open | 12/329/509/106 |
| Operative procedure | |
| Part/Seg/Lob/Sleeve Lob/Lob + Seg/Lob + CW/Bilob/Pneumo | 173/74/643/6/3/12/18/27 |
| Stage (IA/IB/IIA/IIB/IIIA/IIIB/IV/yIA/yIIA) | 563/167/60/81/70/5/4/5/1 |
| Histology (Ad/Sq/LCNEC/AdSq/Pleo/Large/Carci) | 726/180/19/11/9/4/7 |
| Postoperative complication | 257 (26.8%) |
| Clavien-Dindo grade (0/1/2/3a/3b) | 699/1/101/146/9 |
| Air leakage (%) | 112 (11.7%) |
| Arrhythmia (%) | 58 (6.1%) |
| Atelectasis (%) | 26 (2.7%) |
| Pneumonia (%) | 21 (2.2%) |
| Chylothorax | 6 (0.6%) |
| Cerebral infarction (%) | 5 (0.5%) |
| Bronchopleural fistula | 3 (0.3%) |
| 30-day mortality (%) | 1 (0.1%) |
| 90-day mortality (%) | 3 (0.3%) |
| Postoperative hospital-stay, days, median (range) | 12 (3–100) |
%VC vital capacity, FEV1% forced expiratory volume % in one second, RU right upper, RM right middle, RL right lower, LU left upper, LL left lower, RATS Robot-assisted Thoracic Surgery, C complete, VATS video-assisted thoracic surgery, H hybrid, Part partial resection, Seg segmentectomy, Lob lobectomy, CW chest wall resection, Bilob bilobectomy, Pneumo pneumonectomy, p pathological, y yield to treatment, Ad adenocarcinoma, Sq squamous cell carcinoma, LCNEC large cell neuroendocrine carcinoma, AdSq adenosquamous cell carcinoma, Pleo pleomorphic carcinoma, Large large cell carcinoma, Carci carcinoid